glp 1 drug market GLP-1 Drugs Size to Hit USD 132.79 Bn by 2035 GLP-1 Market Size, Share |

Journal of the European Academy of Dermatology and Venereology

The market had changed enough by the time the institute revisited the topic in 2025 and found some drugs cost-effective at certain prices and formulations

Author Akanksha is a Research Analyst at Verified Market Research, with expertise across Mining, Energy, Chemicals, and Transportation markets

The S&P 500's 3 Best-Performing Stocks So Far in 2026 Last quarter, the company submitted its drug orforglipron, a new GLP-1 agonist, for obesity treatment in the United States and more than three dozen additional countries, with an expected domestic launch by mid-2026

doi: 10.1080/13543784.2023.2283020

454 By reducing MMP expression, GLP-1R stimulation may help preserve the integrity of fibrous caps and mitigate the risk of plaque rupture